288 related articles for article (PubMed ID: 28509588)
1. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.
Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD
Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
3. Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization.
Ebrahimian M; Mahvelati F; Malaekeh-Nikouei B; Hashemi E; Oroojalian F; Hashemi M
Appl Biochem Biotechnol; 2022 Aug; 194(8):3733-3748. PubMed ID: 35507250
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression.
Ahrari A; Najafzadehvarzi H; Taravati A; Tohidi F
Life Sci; 2021 Nov; 284():119884. PubMed ID: 34389401
[TBL] [Abstract][Full Text] [Related]
5. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.
Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X
Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858
[TBL] [Abstract][Full Text] [Related]
7. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity.
Wang L; Wang Y; Wang X; Sun L; Zhou Z; Lu J; Zheng Y
J Microencapsul; 2016 Feb; 33(1):43-52. PubMed ID: 26626402
[TBL] [Abstract][Full Text] [Related]
11. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
Nguyen VH; Le KNM; Nguyen MCN
Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
13. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
14. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
15. Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release.
Ghaffarzadegan R; Khoee S; Rezazadeh S
Daru; 2020 Jun; 28(1):237-252. PubMed ID: 32307652
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
[TBL] [Abstract][Full Text] [Related]
17. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
Cui F; Shi K; Zhang L; Tao A; Kawashima Y
J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid-polymer hybrid nanoparticle-mediated transfollicular delivery of quercetin: prospective implement for the treatment of androgenic alopecia.
Das L; Kaurav M; Pandey RS
Drug Dev Ind Pharm; 2019 Oct; 45(10):1654-1663. PubMed ID: 31382790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
